CA Stock MarketDetailed Quotes

EBM Eastwood Bio-Medical Canada Inc

Watchlist
  • 1.000
  • 0.0000.00%
15min DelayMarket Closed Nov 13 16:00 ET
68.89MMarket Cap-100000P/E (TTM)

Eastwood Bio-Medical Canada Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jul 31, 2024
(Q2)Apr 30, 2024
(Q1)Jan 31, 2024
(FY)Oct 31, 2023
(Q4)Oct 31, 2023
(Q3)Jul 31, 2023
(Q2)Apr 30, 2023
(Q1)Jan 31, 2023
(FY)Oct 31, 2022
(Q4)Oct 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-521.68%-17.58K
288.22%11.47K
88.35%-1.23K
-293.29%-16.89K
123.26%2.63K
54.79%-2.83K
-125.08%-6.09K
4.20%-10.59K
96.31%-4.29K
87.60%-11.28K
Net income from continuing operations
1.47%-115.58K
26.00%-130.11K
21.66%-54.24K
-264.69%-546.6K
-638.02%-184.23K
-37.49%-117.3K
-500.81%-175.83K
-569.81%-69.23K
75.17%-149.88K
-363.91%-24.96K
Operating gains losses
----
----
----
-93.18%84
----
----
----
----
--1.23K
----
Depreciation and amortization
-1.21%26.64K
-1.22%26.64K
-1.22%26.64K
0.94%107.85K
0.94%26.96K
0.94%26.96K
0.94%26.96K
0.94%26.96K
1.47%106.85K
0.59%26.71K
Other non cashItems
0.00%9.27K
0.00%9.27K
12.07%10.38K
21.66%4.13K
3.02%-23.67K
0.00%9.27K
-0.01%9.27K
0.01%9.27K
128.65%3.4K
38.47%-24.4K
Change In working capital
-20.64%62.1K
-20.85%105.68K
-28.68%15.98K
1,124.61%417.64K
1,710.32%183.48K
81.62%78.24K
659.13%133.51K
161.07%22.41K
-91.34%34.1K
113.97%10.14K
-Change in receivables
76.51%-3.65K
143.81%3.85K
-264.13%-23.18K
101.45%124
-86.20%10.34K
35.02%-15.55K
80.75%-8.78K
201.68%14.12K
-333.12%-8.57K
2,590.85%74.88K
-Change in prepaid assets
114.50%145
98.71%-200
-48.20%-741
13.49%34.37K
69.63%51.37K
---1K
---15.5K
---500
-18.30%30.28K
--30.28K
-Change in payables and accrued expense
-55.42%44.55K
-32.60%104.96K
524.22%101.42K
466.15%41.43K
-149.01%-230.48K
76.43%99.93K
139.82%155.72K
174.87%16.25K
-97.82%7.32K
13.28%-92.56K
-Change in other working capital
509.57%21.05K
-241.75%-2.93K
-724.87%-61.52K
6,636.17%341.73K
14,401.95%352.26K
-149.57%-5.14K
219.76%2.07K
-573.71%-7.46K
-70.54%5.07K
-1,871.94%-2.46K
Cash from discontinued investing activities
Operating cash flow
-521.68%-17.58K
288.22%11.47K
88.35%-1.23K
-293.29%-16.89K
123.26%2.63K
54.79%-2.83K
-125.08%-6.09K
4.21%-10.59K
96.31%-4.29K
87.60%-11.28K
Investing cash flow
Cash flow from continuing investing activities
0
46.09%-3.01K
Net PPE purchase and sale
----
----
----
--0
----
----
----
----
46.09%-3.01K
----
Cash from discontinued investing activities
Investing cash flow
----
----
----
--0
----
----
----
----
46.09%-3.01K
----
Financing cash flow
Cash flow from continuing financing activities
389.97%22.41K
-137.40%-9.3K
36.20%-11.19K
-117.14%-4.5K
-129.33%-4.11K
-163.11%-7.73K
24.88K
-17.54K
31.35%26.27K
14.03K
Net issuance payments of debt
389.97%22.41K
-137.40%-9.3K
36.20%-11.19K
-117.14%-4.5K
-129.33%-4.11K
-163.11%-7.73K
--24.88K
---17.54K
31.35%26.27K
--14.03K
Cash from discontinued financing activities
Financing cash flow
389.97%22.41K
-137.40%-9.3K
36.20%-11.19K
-117.14%-4.5K
-129.33%-4.11K
-163.11%-7.73K
--24.88K
---17.54K
31.35%26.27K
--14.03K
Net cash flow
Beginning cash position
-73.14%8.19K
-48.55%6.02K
-53.69%18.45K
90.91%39.84K
-50.28%19.94K
-10.61%30.49K
19.32%11.71K
90.91%39.84K
-82.99%20.87K
-65.86%40.1K
Current changes in cash
145.71%4.83K
-88.47%2.17K
55.84%-12.42K
-212.76%-21.39K
-468.32%-1.49K
-276.27%-10.56K
-22.70%18.78K
-154.44%-28.13K
118.64%18.97K
99.73%-262
End cash Position
-34.72%13.02K
-73.14%8.19K
-48.55%6.02K
-53.69%18.45K
-53.69%18.45K
-50.28%19.94K
-10.61%30.49K
19.32%11.71K
90.91%39.84K
90.91%39.84K
Free cash from
-521.68%-17.58K
288.22%11.47K
88.35%-1.23K
-131.37%-16.89K
118.37%2.63K
54.79%-2.83K
-125.08%-6.09K
4.21%-10.59K
94.01%-7.3K
85.21%-14.29K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Jul 31, 2024(Q2)Apr 30, 2024(Q1)Jan 31, 2024(FY)Oct 31, 2023(Q4)Oct 31, 2023(Q3)Jul 31, 2023(Q2)Apr 30, 2023(Q1)Jan 31, 2023(FY)Oct 31, 2022(Q4)Oct 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -521.68%-17.58K288.22%11.47K88.35%-1.23K-293.29%-16.89K123.26%2.63K54.79%-2.83K-125.08%-6.09K4.20%-10.59K96.31%-4.29K87.60%-11.28K
Net income from continuing operations 1.47%-115.58K26.00%-130.11K21.66%-54.24K-264.69%-546.6K-638.02%-184.23K-37.49%-117.3K-500.81%-175.83K-569.81%-69.23K75.17%-149.88K-363.91%-24.96K
Operating gains losses -------------93.18%84------------------1.23K----
Depreciation and amortization -1.21%26.64K-1.22%26.64K-1.22%26.64K0.94%107.85K0.94%26.96K0.94%26.96K0.94%26.96K0.94%26.96K1.47%106.85K0.59%26.71K
Other non cashItems 0.00%9.27K0.00%9.27K12.07%10.38K21.66%4.13K3.02%-23.67K0.00%9.27K-0.01%9.27K0.01%9.27K128.65%3.4K38.47%-24.4K
Change In working capital -20.64%62.1K-20.85%105.68K-28.68%15.98K1,124.61%417.64K1,710.32%183.48K81.62%78.24K659.13%133.51K161.07%22.41K-91.34%34.1K113.97%10.14K
-Change in receivables 76.51%-3.65K143.81%3.85K-264.13%-23.18K101.45%124-86.20%10.34K35.02%-15.55K80.75%-8.78K201.68%14.12K-333.12%-8.57K2,590.85%74.88K
-Change in prepaid assets 114.50%14598.71%-200-48.20%-74113.49%34.37K69.63%51.37K---1K---15.5K---500-18.30%30.28K--30.28K
-Change in payables and accrued expense -55.42%44.55K-32.60%104.96K524.22%101.42K466.15%41.43K-149.01%-230.48K76.43%99.93K139.82%155.72K174.87%16.25K-97.82%7.32K13.28%-92.56K
-Change in other working capital 509.57%21.05K-241.75%-2.93K-724.87%-61.52K6,636.17%341.73K14,401.95%352.26K-149.57%-5.14K219.76%2.07K-573.71%-7.46K-70.54%5.07K-1,871.94%-2.46K
Cash from discontinued investing activities
Operating cash flow -521.68%-17.58K288.22%11.47K88.35%-1.23K-293.29%-16.89K123.26%2.63K54.79%-2.83K-125.08%-6.09K4.21%-10.59K96.31%-4.29K87.60%-11.28K
Investing cash flow
Cash flow from continuing investing activities 046.09%-3.01K
Net PPE purchase and sale --------------0----------------46.09%-3.01K----
Cash from discontinued investing activities
Investing cash flow --------------0----------------46.09%-3.01K----
Financing cash flow
Cash flow from continuing financing activities 389.97%22.41K-137.40%-9.3K36.20%-11.19K-117.14%-4.5K-129.33%-4.11K-163.11%-7.73K24.88K-17.54K31.35%26.27K14.03K
Net issuance payments of debt 389.97%22.41K-137.40%-9.3K36.20%-11.19K-117.14%-4.5K-129.33%-4.11K-163.11%-7.73K--24.88K---17.54K31.35%26.27K--14.03K
Cash from discontinued financing activities
Financing cash flow 389.97%22.41K-137.40%-9.3K36.20%-11.19K-117.14%-4.5K-129.33%-4.11K-163.11%-7.73K--24.88K---17.54K31.35%26.27K--14.03K
Net cash flow
Beginning cash position -73.14%8.19K-48.55%6.02K-53.69%18.45K90.91%39.84K-50.28%19.94K-10.61%30.49K19.32%11.71K90.91%39.84K-82.99%20.87K-65.86%40.1K
Current changes in cash 145.71%4.83K-88.47%2.17K55.84%-12.42K-212.76%-21.39K-468.32%-1.49K-276.27%-10.56K-22.70%18.78K-154.44%-28.13K118.64%18.97K99.73%-262
End cash Position -34.72%13.02K-73.14%8.19K-48.55%6.02K-53.69%18.45K-53.69%18.45K-50.28%19.94K-10.61%30.49K19.32%11.71K90.91%39.84K90.91%39.84K
Free cash from -521.68%-17.58K288.22%11.47K88.35%-1.23K-131.37%-16.89K118.37%2.63K54.79%-2.83K-125.08%-6.09K4.21%-10.59K94.01%-7.3K85.21%-14.29K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data